查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
2030 年基因組學市場預測：按產品、服務、技術、應用、最終用戶和地區進行的全球分析
市場調查報告書
商品編碼
1383304

2030 年基因組學市場預測：按產品、服務、技術、應用、最終用戶和地區進行的全球分析

Genomics Market Forecasts to 2030 - Global Analysis By Product (Consumables & Reagents, Instruments/Systems/Software and Other Products), Service, Study Type, Technology, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據Stratistics MRC預測，2023年全球基因組學市場規模將達到462億美元，預計2030年將達到1,184億美元，預測期內年複合成長率為14.4%。

生物體整個基因組或基因集合的研究是基因體學科學領域的核心。生物體中的所有基因、它們的作用、相互作用以及 DNA 的結構和排列都得到了分析和表徵。它在許多領域也有應用，包括醫學、農業和演化生物學。在基因組研究中，DNA序列測定和生物資訊學等技術經常用於收集和解釋遺傳資料。

據美國癌症研究所稱，到 2040 年，將有 2,950 萬新發癌症病例，並有 1,640 萬癌症相關死亡病例。

專業醫學中的基因組學

許多製藥公司正在增加對個人化醫療研究的投資。個人化醫療使醫生能夠確定患者的確切需求並相應地開出藥物和治療方法。此策略可確保更好的醫療保健結果。個人化醫療業務的成長將為參與企業創造許多機會。

處理精密設備

基因編輯、擴增、定序和多重分析只是基因組研究中使用的一些複雜而精細的技術。這些技術包括使用先進的工具，如定序儀、離心機、分析儀、液體處理設備、PCR 設備和微陣列設備。因此，使用所有設備時必須格外小心。處理如此精密的設備是市場成長的主要障礙。

癌症發生率增加

癌症的流行和次世代定序儀在癌症研究中的日益廣泛使用是市場擴張的關鍵因素。基因組學正在改變癌症的識別和治療方式。由於基因組研究，檢測血液樣本中癌症的方法正在不斷改進。基因組研究導致遺傳性癌症篩檢測試的增加。因此，由於癌症盛行率的上升以及基因組學在癌症診斷和治療中的有效應用，市場正在擴大。

成本和承受能力

儘管核酸定序技術取得了進步，但全基因組序列測定和全面的基因組分析仍然是最昂貴的基因組測試和分析之一。基因組學在臨床實踐中的廣泛使用受到基因檢測及其解釋相關的高成本的限制，特別是在資源有限的地區和經濟弱勢群體中。基因組產品和服務的可得性和可近性也受到財務因素的影響，限制了產業的擴張。

COVID-19 的影響：

在大流行的早期階段，COVID-19 的影響略有上升。這是由於個人化醫療、癌症研究和其他研究的配合措施減少。疫情也擾亂了整個市場，導致售後服務難以提供，一些學術機構暫時關閉。為了檢查病毒的遺傳物質，該研究所採用了聚合酶鍊式反應（PCR）和次世代定序儀（NGS）。

預計途徑分析部分在預測期內將是最大的

路徑分析部分預計將在預測期內成為最大的部分。途徑分析最迅速擴展的應用是下一代治療方法的創建。自從臨床基因組學和客製化治療出現以來，基於途徑的分析引起了人們的興趣。這主要歸功於遺傳學和個體化療法提供的幫助，以詳細研究導航疾病網路和訊號途徑的能力。

研究機構部門預計在預測期內年複合成長率最高

研究機構領域預計在預測期內年複合成長率最高。以基因組學為重點的研究、公共和私人基金會的資金籌措、商業合作夥伴關係等是該細分市場主導基因組學服務市場的部分原因。此外，由於與其他學術機構、醫院和生物技術公司的合作研究，研究機構類別預計將在預測期內快速成長。

比最大的地區

在研究機構和製藥巨頭的支持下，預計北美在預測期內將佔據最大的市場佔有率。由於基因表現對人類健康的影響，基因組學現已成為所有疾病研究和治療開發的關鍵組成部分。此外，支持該行業不斷擴大技術進步的最先進的醫療保健基礎設施的存在以及該地區對生物技術服務不斷成長的需求預計將支持該地區的成長。

複合年複合成長率最高的地區：

由於診斷和新療法中基因組學應用的需求不斷增加，以應對不斷增加的疾病發生率，預計亞太地區在預測期內將保持最高的年複合成長率。此外，癌症等慢性病盛行率的上升、政府研究經費的增加以及消費者意識的提高，都有助於該區域市場的擴張。

免費客製化服務

訂閱此報告的客戶可以存取以下免費自訂選項之一：

  • 公司簡介
    • 其他市場參與者的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計、預測和年複合成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章 執行摘要

第2章 前言

  • 概述
  • 利害關係人
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 調查來源
    • 主要調查來源
    • 二次調查來源
    • 先決條件

第3章 市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 產品分析
  • 技術分析
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • 新型冠狀病毒感染疾病（COVID-19）的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章 全球基因組市場：依產品

  • 消耗品和試劑
  • 設備/系統/軟體
  • 其他產品

第6章 全球基因組市場：依服務分類

  • 核心基因組學服務
  • 計算服務
  • 基於NGS的服務
  • 生物標記翻譯服務
  • 其他服務

第7章 全球基因組市場：依技術分類

  • 表觀基因
    • 染色質免疫沉澱（ChIP 和 ChIP-Seq）
    • 染色質可及性測定
    • 高解析度熔體 (HRM)
    • 亞硫酸氫鹽序列
    • 甲基化 DNA 免疫沉澱 (MeDIP)
    • 微陣列分析
  • 生物標記發現
    • 即時螢光定量PCR
    • 質譜
    • 微陣列分析
    • 統計分析
    • DNA序列測定
    • 生物資訊學
  • 途徑分析
    • 微陣列分析
    • 蛋白質體學工具
    • 即時螢光定量PCR
    • 基於微珠的分析
  • 功能基因體學
    • 即時螢光定量PCR
    • 突變分析
    • RNA干擾
    • 單核苷酸多態性分析
    • 轉染
    • 微陣列分析
  • 其他技術

第8章 全球基因體學市場：依應用分類

  • 農業和動物研究
  • 藥物研發發現與開發
  • 其他用途
    • 生物燃料研究
    • 海洋研究
    • 食品工業
    • 法醫學

第9章 全球基因組市場：依最終用戶分類

  • 製藥和生物技術公司
  • 醫院
  • 診斷中心
  • 學術機構
  • 臨床研究
  • 醫療機構
  • 其他最終用戶

第10章 全球基因組市場：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲

第11章進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第12章公司簡介

  • BGI Genomics
  • Myriad Genetics, Inc.
  • Agilent Technologies
  • Quest Diagnostics Incorporated
  • Thermo Fisher Scientific, Inc.
  • Eurofins Scientific
  • Danaher Corporation
  • Eppendorf AG
  • Bio-Rad Laboratories, Inc.
  • Color Genomics, Inc.
  • Agilent Technologies
  • F. Hoffmann-La Roche Ltd.
  • GE Healthcare
  • Illumina, Inc.
  • Oxford Nanopore Technologies
  • Quest Diagnostics Incorporated
  • Pacific Biosciences of California, Inc.
  • Color Health, Inc.
Product Code: SMRC24154

According to Stratistics MRC, the Global Genomics Market is accounted for $46.2 billion in 2023 and is expected to reach $118.4 billion by 2030 growing at a CAGR of 14.4% during the forecast period. The study of an organism's whole genome, or collection of genes, is at the center of the scientific discipline known as genomics. All genes, their roles, interactions, and the structure and arrangement of the DNA within an organism are analyzed and characterized. It also has many applications in fields including medicine, agriculture, evolutionary biology, and more. Techniques like DNA sequencing and bioinformatics are frequently used in genomic research to collect and interpret genetic data.

According to the National Cancer Institute, by 2040, the number of new cancer cases is expected to rise by 29.5 million, while cancer-related fatalities will rise by 16.4 million.

Market Dynamics:

Driver:

Genomics in specialty medicine

Numerous pharmaceutical firms are making growing investments in the study of tailored medicine. With the use of personalized medicine, doctors can pinpoint a patient's precise needs and then prescribe medications and therapies in response. Better healthcare results are ensured by this strategy. Numerous possibilities for market participants will arise as a result of the growth of the customized medicine business.

Restraint:

Delicate instrument handling

Gene editing, amplification, sequencing, and multiplexing are just a few of the complicated and delicate techniques used in genomic investigations. These techniques include the use of sophisticated tools, including sequencers, centrifuges, analyzers, liquid handling equipment, and PCR and microarray equipment. Therefore, extreme caution must be used when using all of the devices. Handling such delicate devices is a significant market growth inhibitor.

Opportunity:

Increasing cancer rates

The prevalence of cancer and the growing use of next-generation sequencing in cancer research are important drivers of the market's expansion. The way cancer is identified and treated is changing as a result of genomics. The methods for detecting cancer from a blood sample are getting better because to genome research. Genomic research has led to a rise in hereditary cancer screening tests. As a result, the market is expanding due to the rising incidence of cancer and the effective use of genomics in cancer diagnosis and treatment.

Threat:

Cost and affordability

Despite improvements in DNA sequencing technology, whole genome sequencing and comprehensive genomic profiling are among the most costly genomic tests and analyses. The broad use of genomics in clinical practice is constrained by the high costs involved with genetic testing and interpretation, particularly in locations with limited resources or for people with poor financial means. The availability and accessibility of genomic goods and services are also impacted by financial a factor, which restrains the expansion of the industry.

COVID-19 Impact:

The early stage of the pandemic saw a little negative rise in the COVID-19 effect. This was caused by a decline in personalized medicine, cancer research, and other research efforts. The epidemic also caused difficulties in delivering post-sales services and the temporary closure of some academic institutions, which disrupted the market as a whole. To examine viral genetic material, laboratories employed the polymerase chain reaction (PCR) and next-generation sequencing (NGS).

The pathway analysis segment is expected to be the largest during the forecast period

The pathway analysis segment is expected to be the largest during the forecast period. One of the most rapidly expanding uses of route analysis is the creation of next-generation therapies. Since the advent of clinical genomics and tailored treatments, pathway-based analysis has drawn increased interest. This is mostly due to the assistance provided by genetics and individualized medicines for the in-depth investigation of the capacity to navigate illness networks and signaling pathways.

The research institutes segment is expected to have the highest CAGR during the forecast period

The research institutes segment is expected to have the highest CAGR during the forecast period. Researchers with a focus on genomics, financing from public and private foundations, and business partnerships are some of the reasons that contribute to the segment's dominance in the market for genomics services. Additionally, the research institutes category is anticipated to grow faster throughout the projection period due to collaborations with other academic institutions, hospitals, and biotechnology firms.

Region with largest share:

North America is projected to hold the largest market share during the forecast period due to the support of research institutes and pharmaceutical giants. Due to the effects of genetic expression on human health, genomics is now a crucial component of all illness research and therapeutic development. Additionally, the presence of cutting-edge healthcare infrastructure, which supports the expansion of technical advancements in this industry, and rising demand for biotechnology services in the area are anticipated to support regional growth.

Region with highest CAGR:

Asia Pacific is projected to hold the highest CAGR over the forecast period due to increased demand for genomics applications in diagnostics and the growing demand for novel therapeutic drugs to fight the increased incidence of diseases. Additionally, the rising incidence of chronic illnesses like cancer, greater government funding for research, and growing consumer awareness all contribute to the expansion of regional markets.

Key players in the market

Some of the key players in Genomics market include: BGI Genomics, Myriad Genetics, Inc., Agilent Technologies, Quest Diagnostics Incorporated, Thermo Fisher Scientific, Inc., Eurofins Scientific, Danaher Corporation, Eppendorf AG, Bio-Rad Laboratories, Inc., Color Genomics, Inc., Agilent Technologies, F. Hoffmann-La Roche Ltd., GE Healthcare, Illumina, Inc., Oxford Nanopore Technologies, Quest Diagnostics Incorporated, Pacific Biosciences of California, Inc. and Color Health, Inc.

Key Developments:

In June 2023, BGI Genomics was recognized as the GB/T 35770-2022/ISO 37301 Compliance Management System accreditation-approved company, after the extensive evaluation of BSI, a global testing, standardization, and certification authority.

In June 2023, Myriad Genetics and The University of Texas MD Anderson Cancer Center announced their collaboration aimed at metastatic renal cell carcinoma treatment selection and response research and incorporating Myriad's minimal residual disease testing platform based on whole genome sequencing.

In April 2023, Bio-Rad Laboratories, Inc. pivoted their measurable residual disease (MRD) genomics research via a half dozen collaborations with companies and institutions to launch their new QX600™ Droplet Digital™ PCR System.

Products Covered:

  • Consumables & Reagents
  • Instruments/Systems/Software
  • Other Products

Services Covered:

  • Core Genomics Services
  • Computational Services
  • NGS-based Services
  • Biomarker Translation Services
  • Other Services

Technologies Covered:

  • Epigenomics
  • Biomarker Discovery
  • Pathway Analysis
  • Functional Genomics
  • Other Technologies

Applications Covered:

  • Agriculture and Animal research
  • Drug Discovery and Development
  • Other Applications

End Users Covered:

  • Pharmaceutical & Biotechnology Companies
  • Hospitals
  • Diagnostics Centers
  • Academic Institutes
  • Clinical Research
  • Healthcare Facilities
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Technology Analysis
  • 3.7 Application Analysis
  • 3.9 End User Analysis
  • 3.10 Emerging Markets
  • 3.11 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Genomics Market, By Product

  • 5.1 Introduction
  • 5.2 Consumables & Reagents
  • 5.3 Instruments/Systems/Software
  • 5.4 Other Products

6 Global Genomics Market, By Service

  • 6.1 Introduction
  • 6.2 Core Genomics Services
  • 6.3 Computational Services
  • 6.4 NGS-based Services
  • 6.5 Biomarker Translation Services
  • 6.6 Other Services

7 Global Genomics Market, By Technology

  • 7.1 Introduction
  • 7.2 Epigenomics
    • 7.2.1 Chromatin Immunoprecipitation (ChIP & ChIP-Seq)
    • 7.2.2 Chromatin Accessibility Assays
    • 7.2.3 High-Resolution Melt (HRM)
    • 7.2.4 Bisulfite Sequencing
    • 7.2.5 Methylated DNA Immunoprecipitation (MeDIP)
    • 7.2.6 Microarray Analysis
  • 7.3 Biomarker Discovery
    • 7.3.1 Real-time PCR
    • 7.3.2 Mass Spectrometry
    • 7.3.3 Microarray Analysis
    • 7.3.4 Statistical Analysis
    • 7.3.5 DNA Sequencing
    • 7.3.6 Bioinformatics
  • 7.4 Pathway Analysis
    • 7.4.1 Microarray Analysis
    • 7.4.2 Proteomics Tools
    • 7.4.3 Real-time PCR
    • 7.4.4 Bead-Based Analysis
  • 7.5 Functional Genomics
    • 7.5.1 Real-Time PCR
    • 7.5.2 Mutational Analysis
    • 7.5.3 RNA Interference
    • 7.5.4 SNP Analysis
    • 7.5.5 Transfection
    • 7.5.6 Microarray Analysis
  • 7.6 Other Technologies

8 Global Genomics Market, By Application

  • 8.1 Introduction
  • 8.2 Agriculture and Animal research
  • 8.3 Drug Discovery and Development
  • 8.4 Other Applications
    • 8.4.1 Biofuel Research
    • 8.4.2 Marine Research
    • 8.4.3 Food Industry
    • 8.4.4 Forensics

9 Global Genomics Market, By End User

  • 9.1 Introduction
  • 9.2 Pharmaceutical & Biotechnology companies
  • 9.4 Hospitals
  • 9.5 Diagnostics Centers
  • 9.6 Academic Institutes
  • 9.8 Clinical Research
  • 9.9 Healthcare Facilities
  • 9.9 Other End Users

10 Global Genomics Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 BGI Genomics
  • 12.2 Myriad Genetics, Inc.
  • 12.3 Agilent Technologies
  • 12.4 Quest Diagnostics Incorporated
  • 12.5 Thermo Fisher Scientific, Inc.
  • 12.6 Eurofins Scientific
  • 12.7 Danaher Corporation
  • 12.7 Eppendorf AG
  • 12.9 Bio-Rad Laboratories, Inc.
  • 12.10 Color Genomics, Inc.
  • 12.11 Agilent Technologies
  • 12.12 F. Hoffmann-La Roche Ltd.
  • 12.12 GE Healthcare
  • 12.14 Illumina, Inc.
  • 12.15 Oxford Nanopore Technologies
  • 12.16 Quest Diagnostics Incorporated
  • 12.17 Pacific Biosciences of California, Inc.
  • 12.17 Color Health, Inc.

List of Tables

  • Table 1 Global Genomics Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Genomics Market Outlook, By Product (2021-2030) ($MN)
  • Table 3 Global Genomics Market Outlook, By Consumables & Reagents (2021-2030) ($MN)
  • Table 4 Global Genomics Market Outlook, By Instruments/Systems/Software (2021-2030) ($MN)
  • Table 5 Global Genomics Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 6 Global Genomics Market Outlook, By Service (2021-2030) ($MN)
  • Table 7 Global Genomics Market Outlook, By Core Genomics Services (2021-2030) ($MN)
  • Table 8 Global Genomics Market Outlook, By Computational Services (2021-2030) ($MN)
  • Table 9 Global Genomics Market Outlook, By NGS-based Services (2021-2030) ($MN)
  • Table 10 Global Genomics Market Outlook, By Biomarker Translation Services (2021-2030) ($MN)
  • Table 11 Global Genomics Market Outlook, By Other Services (2021-2030) ($MN)
  • Table 12 Global Genomics Market Outlook, By Technology (2021-2030) ($MN)
  • Table 13 Global Genomics Market Outlook, By Epigenomics (2021-2030) ($MN)
  • Table 14 Global Genomics Market Outlook, By Chromatin Immunoprecipitation (ChIP & ChIP-Seq) (2021-2030) ($MN)
  • Table 15 Global Genomics Market Outlook, By Chromatin Accessibility Assays (2021-2030) ($MN)
  • Table 16 Global Genomics Market Outlook, By High-Resolution Melt (HRM) (2021-2030) ($MN)
  • Table 17 Global Genomics Market Outlook, By Bisulfite Sequencing (2021-2030) ($MN)
  • Table 18 Global Genomics Market Outlook, By Methylated DNA Immunoprecipitation (MeDIP) (2021-2030) ($MN)
  • Table 19 Global Genomics Market Outlook, By Microarray Analysis (2021-2030) ($MN)
  • Table 20 Global Genomics Market Outlook, By Biomarker Discovery (2021-2030) ($MN)
  • Table 21 Global Genomics Market Outlook, By Real-time PCR (2021-2030) ($MN)
  • Table 22 Global Genomics Market Outlook, By Mass Spectrometry (2021-2030) ($MN)
  • Table 23 Global Genomics Market Outlook, By Microarray Analysis (2021-2030) ($MN)
  • Table 24 Global Genomics Market Outlook, By Statistical Analysis (2021-2030) ($MN)
  • Table 25 Global Genomics Market Outlook, By DNA Sequencing (2021-2030) ($MN)
  • Table 26 Global Genomics Market Outlook, By Bioinformatics (2021-2030) ($MN)
  • Table 27 Global Genomics Market Outlook, By Pathway Analysis (2021-2030) ($MN)
  • Table 28 Global Genomics Market Outlook, By Microarray Analysis (2021-2030) ($MN)
  • Table 29 Global Genomics Market Outlook, By Proteomics Tools (2021-2030) ($MN)
  • Table 30 Global Genomics Market Outlook, By Real-time PCR (2021-2030) ($MN)
  • Table 31 Global Genomics Market Outlook, By Bead-Based Analysis (2021-2030) ($MN)
  • Table 32 Global Genomics Market Outlook, By Functional Genomics (2021-2030) ($MN)
  • Table 33 Global Genomics Market Outlook, By Real-Time PCR (2021-2030) ($MN)
  • Table 34 Global Genomics Market Outlook, By Mutational Analysis (2021-2030) ($MN)
  • Table 35 Global Genomics Market Outlook, By RNA Interference (2021-2030) ($MN)
  • Table 36 Global Genomics Market Outlook, By SNP Analysis (2021-2030) ($MN)
  • Table 37 Global Genomics Market Outlook, By Transfection (2021-2030) ($MN)
  • Table 38 Global Genomics Market Outlook, By Microarray Analysis (2021-2030) ($MN)
  • Table 39 Global Genomics Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 40 Global Genomics Market Outlook, By Application (2021-2030) ($MN)
  • Table 41 Global Genomics Market Outlook, By Agriculture and Animal research (2021-2030) ($MN)
  • Table 42 Global Genomics Market Outlook, By Drug Discovery and Development (2021-2030) ($MN)
  • Table 43 Global Genomics Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 44 Global Genomics Market Outlook, By Biofuel Research (2021-2030) ($MN)
  • Table 45 Global Genomics Market Outlook, By Marine Research (2021-2030) ($MN)
  • Table 46 Global Genomics Market Outlook, By Food Industry (2021-2030) ($MN)
  • Table 47 Global Genomics Market Outlook, By Forensics (2021-2030) ($MN)
  • Table 48 Global Genomics Market Outlook, By End User (2021-2030) ($MN)
  • Table 49 Global Genomics Market Outlook, By Pharmaceutical & Biotechnology Companies (2021-2030) ($MN)
  • Table 50 Global Genomics Market Outlook, By Hospitals and Clinics (2021-2030) ($MN)
  • Table 51 Global Genomics Market Outlook, By Diagnostics Centers (2021-2030) ($MN)
  • Table 52 Global Genomics Market Outlook, By Academic Institutes (2021-2030) ($MN)
  • Table 53 Global Genomics Market Outlook, By Clinical Research (2021-2030) ($MN)
  • Table 54 Global Genomics Market Outlook, By Healthcare Facilities (2021-2030) ($MN)
  • Table 55 Global Genomics Market Outlook, By Other End Users (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.